hexamethylbenzene has been researched along with ruthenium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habtemariam, A; Melchart, M; Peacock, AF; Sadler, PJ; Yan, YK | 1 |
| Baik, MH; Lord, RL; Schauer, CK; Schultz, FA | 1 |
| Dyson, PJ; Govender, P; Riedel, T; Smith, GS | 1 |
| Caruso, A; Caruso, F; Gariboldi, MB; Marchetti, F; Monti, E; Pettinari, C; Pettinari, R; Ramani, MV; Rossi, M; Subbaraju, GV | 1 |
4 other study(ies) available for hexamethylbenzene and ruthenium
| Article | Year |
|---|---|
Catalysis of regioselective reduction of NAD+ by ruthenium(II) arene complexes under biologically relevant conditions.
Topics: Antineoplastic Agents; Benzene Derivatives; Catalysis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; NAD; Organometallic Compounds; Oxidation-Reduction; Ruthenium; Structure-Activity Relationship | 2006 |
Ring-slippage and multielectron redox properties of Fe/Ru/Os-bis(arene) complexes: does hapticity change really cause potential inversion?
Topics: Benzene Derivatives; Iron; Molecular Structure; Organometallic Compounds; Osmium; Oxidation-Reduction; Ruthenium | 2011 |
Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Cyclopentanes; Cymenes; Dendrimers; DNA; HEK293 Cells; Humans; Iridium; Models, Molecular; Monoterpenes; Pyridines; Rhodium; Ruthenium; Schiff Bases | 2016 |
The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Benzene; Benzene Derivatives; Cell Line, Tumor; Coordination Complexes; Curcumin; Cymenes; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; MCF-7 Cells; Monoterpenes; Organ Specificity; Ruthenium; Structure-Activity Relationship | 2016 |